Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
02/1995
02/08/1995EP0637247A1 Treatment of herpesvirus infection
02/08/1995EP0536203B1 COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS
02/07/1995US5387673 Active fragments of fibroblast growth factor
02/07/1995US5387671 Antiinflammatory agents
02/07/1995US5387670 Antibiotic, deoxymulundocandin, a process for its production and its use as medicament
02/07/1995US5387414 Comprising peptide immunogen with novel epitopes
02/07/1995CA1334287C Biologically active peptides tan-866
02/02/1995WO1995003330A1 Somatostatin derivatives and their radiolabelled products
02/02/1995WO1995003327A2 Peptides for neutralizing the toxicity of lipid a
02/02/1995WO1995003325A1 Protegrins
02/02/1995WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists
02/02/1995WO1995003280A1 Hydrazino-type radionuclide chelators having an n3s configuration
02/02/1995CA2168232A1 Recombinant c140 receptor and its agonists and antagonists
02/02/1995CA2167167A1 Hydrazino-type radionuclide chelators having an n3s configuration
02/02/1995CA2166788A1 Protegrins
02/01/1995EP0636145A1 Synthetic polypeptides derived from the hiv envelope glycoprotein
02/01/1995EP0636032A1 Method of intraoperatively detecting and locating tumoral tissues
02/01/1995EP0636028A1 Self-assembling polynucleotide delivery system
01/1995
01/31/1995US5386011 Hexapeptide anaphylatoxin-receptor ligands
01/31/1995US5386010 Water-soluble, inhalable echinocandins; fungicides; antiprotozoa agents, yeasts
01/31/1995US5386009 Water-soluble, injectible echinocandins; fungicides; antiprotozoa agents, yeasts
01/31/1995US5385889 Substitution of L-proline at the 7-position of the peptide hormone with a D-configuration hydroxyproline ether or thioether converts agonist into antagonist
01/31/1995US5385884 Water-soluble, injectible echinocandins; fungicides; antiprotozoa agents, yeasts
01/31/1995CA1334180C Antibiotics r106
01/27/1995CA2128547A1 Method for the separation of bacterial lipopolysaccharides from protein-containing solutions
01/26/1995WO1995002609A1 Peptides exhibiting oxytocin antagonistic activity
01/26/1995WO1994028014A3 Peptide inhibitors of urokinase receptor activity
01/26/1995CA2163114A1 Peptides exhibiting oxytocin antagonistic activity
01/25/1995EP0635573A2 Process for the preparation of native human glicentin
01/25/1995EP0635027A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
01/25/1995EP0635025A1 Process for preparing modified proteins
01/25/1995CN1097597A Cyclosporin soft capsule composition
01/24/1995US5384309 Anticoagulants
01/24/1995US5384263 Method to produce immunodiagnostic reagents
01/24/1995US5384113 Gentisic acid, alcohol or derivatives
01/23/1995CA2128552A1 Derivatives of 6,7-dihydroxy-4-thiaheptanoic acid and their use
01/19/1995WO1995001993A1 COMPOUNDS HAVING THE ANTIGENICITY OF hCG
01/19/1995WO1995001991A1 Allatostatins and their use
01/19/1995WO1995001990A1 Hemoregulatory penta- or hexapeptides
01/19/1995WO1995001800A1 Cyclic semi-random peptide libraries
01/19/1995CA2166385A1 Compounds having the antigenicity of hcg
01/18/1995EP0603307A4 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same.
01/18/1995EP0565567B1 Amides of antibiotic ge 2270 factors
01/18/1995EP0406316B1 Peptides derived from Foot and mouth disease virus
01/18/1995EP0394296B1 Assay of a body fluid for measuring bone resorption
01/17/1995US5382655 Process for the purification of cyclosporin A
01/17/1995US5382569 Hexapeptides for cardiovascular disorders
01/17/1995US5382568 Regulating release of prolactin and luteinizing hormone
01/12/1995WO1995001376A1 Peptide inhibitors of mitogenesis and motogenesis
01/12/1995WO1995001373A1 Process for manufacture of 1-deamino-8-d-arginine vasopressin
01/12/1995WO1995001372A1 Peptidase resistant thrombin receptor peptide ligand
01/12/1995WO1995001370A1 Higher order structure and binding of peptide nucleic acids
01/12/1995WO1995001369A1 Double-stranded peptide nucleic acids
01/12/1995WO1995001368A1 Improved synthesis of cyclic peptides
01/12/1995WO1995001188A1 Polyvalent peptide pharmaceutical applications
01/12/1995WO1995001182A1 THF-η2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
01/12/1995WO1994022911A3 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE
01/12/1995WO1994019024A3 Technetium-99m labeled peptides for diagnostic imaging
01/12/1995CA2166462A1 Double-stranded peptide nucleic acids
01/12/1995CA2166461A1 Higher order structure and binding of peptide nucleic acids
01/12/1995CA2142713A1 Peptide inhibitors of mitogenesis and motogenesis
01/11/1995EP0632829A1 Thrombin receptor antagonists
01/11/1995EP0632722A1 A dna transporter system and method of use
01/10/1995US5380668 Compounds having the antigenicity of hCG
01/10/1995CA2126819A1 Kit and method for pretargeting
01/05/1995WO1995000846A1 Domain ligation strategy to engineer proteins with unusual architectures
01/05/1995WO1995000653A1 Synthetic antifungal peptides
01/05/1995WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof
01/05/1995WO1995000548A1 Biologically active vasopressin analogues
01/05/1995WO1995000546A1 Endothelin-antagonizing peptide
01/05/1995WO1995000544A1 Method and composition for treating thrombosis
01/05/1995WO1995000543A1 Anti-inflammatory peptides
01/05/1995WO1995000542A1 Bombesin receptor antagonists and uses thereof
01/05/1995WO1995000474A1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES
01/05/1995WO1995000168A1 Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
01/05/1995WO1995000159A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof
01/05/1995WO1994018324A3 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide
01/05/1995CA2165986A1 Synthetic antifungal peptides
01/05/1995CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof
01/05/1995CA2165469A1 Methods of making amino acids useful in preparing gnrh analogs
01/05/1995CA2165332A1 Method and composition for treating thrombosis
01/05/1995CA2163352A1 Biologically active vasopressin analogues
01/05/1995CA2142985A1 Endothelin-antagonizing peptide
01/04/1995EP0632053A2 Cyclic adhesion inhibitors
01/04/1995EP0631502A1 Lymphocyte activity regulation by hla peptides
01/04/1995EP0404935B1 Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1
01/03/1995US5378819 Nucleic acid or DNA for genetic engineering
01/03/1995US5378804 Fungicides, antiprotozoa agents, microbiocides
01/03/1995US5378688 Conjugating luteinizing hormone releasing hormone to plant, bacterialo or chemical toxins
12/1994
12/31/1994CA2127068A1 Process for the preparation of native human glicentin
12/28/1994EP0630255A1 Mhc conjugates useful in ameliorating autoimmunity
12/28/1994EP0528854B1 Fluorogenic peptides and their use in the determination of enzymatic activities
12/27/1994US5376634 Microbiocides
12/25/1994CA2126619A1 Sustained-release preparation of anti-endothelin substance
12/22/1994WO1994029727A1 Inhibiting protein interactions
12/22/1994WO1994029436A1 Methods for selectively stimulating proliferation of t cells
12/22/1994WO1994029349A1 Trifunctional antithrombin and antiplatelet peptides
12/22/1994WO1994029341A1 Methods of enhancing bioactivity of chemokines
12/22/1994WO1994029338A1 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists
12/22/1994WO1994029337A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues